Yu-Ping Li
Overview
Explore the profile of Yu-Ping Li including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
107
Citations
737
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huang J, Ma Q, Qi Y, Wang Z, Liu X, Zhu Y, et al.
Neuromolecular Med
. 2025 Feb;
27(1):15.
PMID: 39979490
This in vivo study explored the impact of TUBB6 inhibition in intracerebral hemorrhage (ICH), focusing on its effects on hematoma volume, microtubule stability, inflammation, neuronal preservation, and sensorimotor recovery. Sprague-Dawley...
2.
Peng W, Li Y, Zeng Y, Chen K
World J Gastrointest Oncol
. 2024 May;
16(5):2074-2090.
PMID: 38764826
Background: Colon cancer is acknowledged as one of the most common malignancies worldwide, ranking third in United States regarding incidence and mortality. Notably, approximately 40% of colon cancer cases harbor...
3.
Gao Y, Lu H, Zheng H, Cao C, Chu D, Fan H, et al.
ERJ Open Res
. 2024 Feb;
10(1).
PMID: 38410702
Chronic (PA) infection significantly contributes to morbidity and mortality in bronchiectasis patients. Initiating antibiotics early may lead to the eradication of PA. Here we outline the design of a trial...
4.
Xu C, Su S, Yu J, Lei X, Lin P, Wu Q, et al.
BMC Pulm Med
. 2024 Jan;
24(1):57.
PMID: 38280994
Background: Currently, there remains insufficient focus on non-severe community-acquired pneumonia (CAP) patients who are at risk of clinical deterioration, and there is also a dearth of research on the related...
5.
Chen D, Xia R, Li Q, Li Y, Cao H, Liu Y
Int J Mol Sci
. 2023 Jun;
24(11).
PMID: 37298726
For a half-century, the commercial wild silkworm, , has been protected by coumaphos, which is an internal organophosphorus insecticide used to kill the potential parasitic fly larvae inside. Knowledge about...
6.
Guo Y, Wu H, Zhang T, Li Y, Yang J, Yang M, et al.
J Neurol
. 2023 Mar;
270(6):2924-2937.
PMID: 36862149
Background: The lack of randomized evidence makes it difficult to establish reliable treatment recommendations for patients with M2 occlusion. This study aims to compare the efficacy and safety of endovascular...
7.
Mei Y, Chen Q, Li Y, Chen Y, Xia J, Zeng J, et al.
Front Mol Neurosci
. 2023 Feb;
16:1128429.
PMID: 36818655
Adenosine 5'-monophosphate (AMP)-activated protein kinase (AMPK) is a pivotal regulatory protein in energy metabolism. In a pilot study, we found that AMPK-associated energy metabolism imbalance in neurons contributes to the...
8.
Zuo Y, Wu Y, Hu W, Chen Y, Li Y, Song Z, et al.
Diagnostics (Basel)
. 2023 Jan;
13(2).
PMID: 36673134
Background: Metagenomic Next Generation Sequencing (mNGS) has the potential to detect pathogens rapidly. We aimed to assess the diagnostic performance of mNGS in hospitalized patients with suspected sepsis and evaluate...
9.
Mei Y, Mu Y, Wang W, Tan B, Chen Y, Li Y, et al.
J Pain Res
. 2022 Oct;
15:3319-3326.
PMID: 36304487
Introduction: Adenosine 5'-monophosphate (AMP)-activated protein kinase (AMPK) can influence energy metabolism. Energy metabolism imbalance is closely associated with the occurrence of neuropathic pain (NeP). Rs10789038 and rs2796498 are genetic polymorphisms...
10.
Zhang S, Yang Y, Sun W, Zhang Z, Xiao H, Li Y, et al.
BMC Infect Dis
. 2022 Aug;
22(1):715.
PMID: 36038829
Objective: Refractory rifampicin-resistant/multidrug resistant/extensively-drug resistant tuberculosis (RR/MDR/XDR-TB) were defined as patients infected with Mycobacterium tuberculosis (MTB) resistant to rifampicin(RR-TB), or at least resistant to rifampicin and isoniazid (MDR-TB) or added...